De Rucci Healthy Sleep Co., Ltd. (SHE:001323)

De Rucci Healthy Sleep Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	5,372	5,522	5,516	5,757	6,416	4,420
Other Revenue	79.38	80.7	62.35	55.31	64.86	32.82
Revenue	5,451	5,603	5,579	5,813	6,481	4,452
Revenue Growth (YoY)	-6.15%	0.43%	-4.03%	-10.31%	45.56%	15.29%
Cost of Revenue	2,713	2,802	2,775	3,113	3,568	2,262
Gross Profit	2,739	2,801	2,803	2,699	2,913	2,191
Selling, General & Admin	1,721	1,713	1,709	1,769	1,911	1,394
Research & Development	207.43	205.28	185.76	158.29	155.08	90.35
Other Operating Expenses	55.09	40.51	36.3	46.99	46.81	36.92
Operating Expenses	1,987	1,961	1,928	1,981	2,116	1,522
Operating Income	751.73	840.48	875.48	718.6	797.17	668.64
Interest Expense	-18.91	-17.88	-8.79	-9.28	-10.85	-2.6
Interest & Investment Income	50.83	65.88	73.24	58.83	39.77	7.8
Currency Exchange Gain (Loss)	-0.21	-4.13	0.83	-5.34	-6.55	4.15
Other Non Operating Income (Expenses)	-8.71	-2.98	-8.59	-8.25	-9.1	-8.32
EBT Excluding Unusual Items	774.72	881.38	932.17	754.56	810.44	669.68
Gain (Loss) on Sale of Investments	71.67	21.42	0.39	0.74	-	-0.09
Gain (Loss) on Sale of Assets	-2.82	-8	7.17	29.31	-4.52	-0.69
Asset Writedown	-0.15	-1.4	-7.41	-1.11	-0.39	-4.05
Other Unusual Items	37.54	25.34	26.98	35.91	10.28	-3.81
Pretax Income	880.95	918.73	959.31	819.4	817.82	662.89
Income Tax Expense	130.15	151.4	157.04	111	131.37	126.58
Earnings From Continuing Operations	750.8	767.33	802.27	708.41	686.44	536.3
Minority Interest in Earnings	1.09	-	-	-	-	0.03
Net Income	751.89	767.33	802.27	708.41	686.44	536.34
Net Income to Common	751.89	767.33	802.27	708.41	686.44	536.34
Net Income Growth	-8.27%	-4.35%	13.25%	3.20%	27.99%	61.06%
Shares Outstanding (Basic)	433	433	439	419	395	351
Shares Outstanding (Diluted)	433	433	439	419	395	351
Shares Change (YoY)	-0.48%	-1.41%	4.80%	5.98%	12.57%	-
EPS (Basic)	1.74	1.77	1.83	1.69	1.74	1.53
EPS (Diluted)	1.74	1.77	1.83	1.69	1.74	1.53
EPS Growth	-7.83%	-2.99%	8.07%	-2.62%	13.69%	-
Free Cash Flow	710.93	709.84	1,539	25.7	226.43	530.18
Free Cash Flow Per Share	1.64	1.64	3.50	0.06	0.57	1.51
Dividend Per Share	1.359	1.591	0.909	1.818	-	-
Dividend Growth	-14.57%	75.00%	-50.00%	-	-	-
Gross Margin	50.24%	49.99%	50.25%	46.44%	44.94%	49.20%
Operating Margin	13.79%	15.00%	15.69%	12.36%	12.30%	15.02%
Profit Margin	13.79%	13.70%	14.38%	12.19%	10.59%	12.05%
Free Cash Flow Margin	13.04%	12.67%	27.59%	0.44%	3.49%	11.91%
EBITDA	963.53	1,049	1,069	893.41	925.05	746.43
EBITDA Margin	17.68%	18.71%	19.17%	15.37%	14.27%	16.77%
D&A For EBITDA	211.8	208.1	193.93	174.81	127.89	77.79
EBIT	751.73	840.48	875.48	718.6	797.17	668.64
EBIT Margin	13.79%	15.00%	15.69%	12.36%	12.30%	15.02%
Effective Tax Rate	14.77%	16.48%	16.37%	13.55%	16.06%	19.10%
Revenue as Reported	5,451	5,603	5,579	5,813	6,481	-
Advertising Expenses	-	768.93	753.11	756.49	831.77	588.93

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.